Advertising regulator launches nine investigations into weight loss jab ads
Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued warning to advertisers for drugs including Ozempic and Wegovy
Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued warning to advertisers for drugs including Ozempic and Wegovy
